3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neuroendocrine Tumors
1
Myeloproliferative Disorders
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Interventions
fludarabine phosphate
19
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
15
Mycophenolic Acid
15
Tacrolimus
12
Cyclosporine
11
Cyclophosphamide
11
Antilymphocyte Serum
11
Busulfan
10
Rituximab
7
Methotrexate
7
Etoposide
6
Melphalan
5
Flow Cytometry
5
Radiotherapy
4
Panobinostat
4
Lenalidomide
4
Filgrastim
4
Everolimus
4
Dexamethasone
4
Calcium Dobesilate
4
thymoglobulin
3
romidepsin
3
pembrolizumab
3
mogamulizumab
3
fludarabine
3
Therapeutics
3
Sirolimus
3
In Situ Hybridization, Fluorescence
3
Immunohistochemistry
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sezary Syndrome
×
entinostat
×
Clear all
No trials found.